These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11751588)

  • 1. Vitronectin binding to IGF binding protein-5 (IGFBP-5) alters IGFBP-5 modulation of IGF-I actions.
    Nam T; Moralez A; Clemmons D
    Endocrinology; 2002 Jan; 143(1):30-6. PubMed ID: 11751588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth.
    Nam TJ; Busby WH; Rees C; Clemmons DR
    Endocrinology; 2000 Mar; 141(3):1100-6. PubMed ID: 10698186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.
    Moralez AM; Maile LA; Clarke J; Busby WH; Clemmons DR
    J Cell Physiol; 2005 May; 203(2):328-34. PubMed ID: 15700281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.
    Imai Y; Busby WH; Smith CE; Clarke JB; Garmong AJ; Horwitz GD; Rees C; Clemmons DR
    J Clin Invest; 1997 Nov; 100(10):2596-605. PubMed ID: 9366575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of IGFBP-5 binding to extracellular matrix and IGF-I-stimulated DNA synthesis by a peptide fragment of IGFBP-5.
    Rees C; Clemmons DR
    J Cell Biochem; 1998 Dec; 71(3):375-81. PubMed ID: 9831074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factors (IGF) and IGF-binding proteins bound to vitronectin enhance keratinocyte protein synthesis and migration.
    Hyde C; Hollier B; Anderson A; Harkin D; Upton Z
    J Invest Dermatol; 2004 May; 122(5):1198-206. PubMed ID: 15140223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I.
    Parker A; Rees C; Clarke J; Busby WH; Clemmons DR
    Mol Biol Cell; 1998 Sep; 9(9):2383-92. PubMed ID: 9725901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin.
    Kricker JA; Towne CL; Firth SM; Herington AC; Upton Z
    Endocrinology; 2003 Jul; 144(7):2807-15. PubMed ID: 12810534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II.
    Gockerman A; Prevette T; Jones JI; Clemmons DR
    Endocrinology; 1995 Oct; 136(10):4168-73. PubMed ID: 7545099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of insulin-like growth factor binding protein-5 protease synthesis and secretion by human fibroblasts and porcine aortic smooth muscle cells.
    Moralez A; Busby WH; Clemmons D
    Endocrinology; 2003 Jun; 144(6):2489-95. PubMed ID: 12746311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that IGF binding protein-5 functions as a ligand-independent transcriptional regulator in vascular smooth muscle cells.
    Xu Q; Li S; Zhao Y; Maures TJ; Yin P; Duan C
    Circ Res; 2004 Mar; 94(5):E46-54. PubMed ID: 15001525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.
    Arai T; Busby W; Clemmons DR
    Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of extracellular matrix proteins on porcine smooth muscle cell insulin-like growth factor (IGF) binding protein-5 synthesis and responsiveness to IGF-I.
    Zheng B; Duan C; Clemmons DR
    J Biol Chem; 1998 Apr; 273(15):8994-9000. PubMed ID: 9535886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I:vitronectin complex-induced changes in gene expression effect breast cell survival and migration.
    Kashyap AS; Hollier BG; Manton KJ; Satyamoorthy K; Leavesley DI; Upton Z
    Endocrinology; 2011 Apr; 152(4):1388-401. PubMed ID: 21303956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic alphaVbeta3 antagonists inhibit insulin-like growth factor-I-stimulated smooth muscle cell migration and replication.
    Clemmons DR; Horvitz G; Engleman W; Nichols T; Moralez A; Nickols GA
    Endocrinology; 1999 Oct; 140(10):4616-21. PubMed ID: 10499518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-binding protein-5 is cleaved by physiological concentrations of thrombin.
    Zheng B; Clarke JB; Busby WH; Duan C; Clemmons DR
    Endocrinology; 1998 Apr; 139(4):1708-14. PubMed ID: 9528953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A protease-resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-1 actions.
    Rees C; Clemmons DR; Horvitz GD; Clarke JB; Busby WH
    Endocrinology; 1998 Oct; 139(10):4182-8. PubMed ID: 9751498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic investigations into interactions between IGF-I and IGFBPs and their impact on facilitating cell migration on vitronectin.
    Kricker JA; Hyde CE; Van Lonkhuyzen DR; Hollier BG; Shooter GK; Leavesley DI; Herington AC; Upton Z
    Growth Factors; 2010 Oct; 28(5):359-69. PubMed ID: 20569097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of recombinant porcine IGF-binding protein-5 and its effect on proliferation of porcine embryonic myoblast cultures in the presence and absence of IGF-I and Long-R3-IGF-I.
    Pampusch MS; Xi G; Kamanga-Sollo E; Loseth KJ; Hathaway MR; Dayton WR; White ME
    J Endocrinol; 2005 Apr; 185(1):197-206. PubMed ID: 15817840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor (IGF) binding protein-5 blocks skeletal muscle differentiation by inhibiting IGF actions.
    Mukherjee A; Wilson EM; Rotwein P
    Mol Endocrinol; 2008 Jan; 22(1):206-15. PubMed ID: 17885206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.